1h Free Analyst Time
The ELISpot & FluoroSpot Assay Market size was estimated at USD 292.68 million in 2023, USD 313.61 million in 2024, and is expected to grow at a CAGR of 7.02% to reach USD 470.74 million by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
ELISpot (enzyme-linked immunosorbent spot) assays are sensitive and potent immunoassays that measure the quantity of antigen-specific T cells by evaluating the number of cytokine-secreting cells. FluoroSpot assays can visualize and enumerate the number of polyfunctional T cells and single-cytokine producers. FluoroSpot assay uses fluorescent labels with discrete, non-overlapping wavelengths to differentiate individual cytokines and co-secreted cytokines. Both ELISPOT and fluoroSpot assays are widely used in immuno-monitoring of clinical trials where both quantitative information and T cell phenotype identification at a single cell level are required. The rising increasing prevalence of chronic diseases across the world and a surge in biomedical research have necessitated the deployment of robust immunological assays for diagnosis and monitoring. Furthermore, the rise in investments in the pharmaceutical and biotechnology sectors, driven by a growing focus on personalized medicine, has expanded the application scope of these assays. However, the complexity of operating the assay and the chances of variability in test results impede the widespread adoption of the assays. Additionally, the difficulty of interpretation of test results and data analysis complexities with ELISpot & FluoroSpot assays further pose complications for utilization of ELISpot and FluoroSpot. However, the healthcare industry's continuous push toward innovation coupled with R&D initiatives aimed towards improving the specificity and accuracy of the assays can overcome the technical constraints of using ELISpot and FluoroSpot assay. A growing emphasis on immunotherapy treatments for cancer and other diseases further creates a significant need for ELISpot and FluoroSpot assays.
Regional Insights
The continued growth of ELISpot and FluoroSpot assays in the Americas region can be credited to its well-established healthcare and biotechnological sectors, significant investments in research and development, and the presence of major market players. Particularly, the United States, with a robust healthcare infrastructure and increased healthcare spending, is driving the growth in this region. Europe is another key region for the ELISpot and FluoroSpot assays, with countries such as Germany, the United Kingdom, France, and Italy leading the growth of the technology. The growth in Europe is driven by advanced healthcare systems and the presence of reputed research institutions. Moreover, collaborations between academic institutions and the industry foster innovation in assay development. The European market also benefits from supportive regulatory policies aimed towards the development of advanced ELISpot and FluoroSpot assays. In the APAC region, the need for ELISpot and FluoroSpot assays is expanding due to increased awareness regarding advanced immunodiagnostic techniques, increased awareness about chronic diseases, and government initiatives aimed at enhancing healthcare outcomes. Furthermore, the presence of contract research organizations (CROs) in this region positions the Asia Pacific as a prominent region for the growth of both assays.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the ELISpot & FluoroSpot Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ELISpot & FluoroSpot Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the ELISpot & FluoroSpot Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Anogen-Yes Biotech Laboratories Ltd, Autoimmun Diagnostika GmbH, Becton, Dickinson and Company, Bio-Techne Corporation, BIOSYS Scientific Devices GmbH, BOC Sciences, Broughton Life Sciences Limited, CellCarta Biosciences Inc., Creative Proteomics, Elabscience, Full Moon BioSystems, Inc., Jackson ImmunoResearch Inc., Mabtech AB, Merck KGaA, Oxford Immunotec USA, Inc., Oy Medix Biochemica Ab, ProImmune Ltd., Quansys Biosciences Inc., SBH Sciences, U-CyTech BV, and ZenBio, Inc.Market Segmentation & Coverage
This research report categorizes the ELISpot & FluoroSpot Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Acessories
- Analyzers
- Assay Kits
- Application
- Autoimmune Disorders
- Infectious Diseases
- Oncology
- Organ Transplantation
- Vaccine Development
- End-User
- Academic Research Institutes
- Hospitals & Clinical Laboratories
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the ELISpot & FluoroSpot Assay Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the ELISpot & FluoroSpot Assay Market?
- What are the technology trends and regulatory frameworks in the ELISpot & FluoroSpot Assay Market?
- What is the market share of the leading vendors in the ELISpot & FluoroSpot Assay Market?
- Which modes and strategic moves are suitable for entering the ELISpot & FluoroSpot Assay Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. ELISpot & FluoroSpot Assay Market, by Product
7. ELISpot & FluoroSpot Assay Market, by Application
8. ELISpot & FluoroSpot Assay Market, by End-User
9. Americas ELISpot & FluoroSpot Assay Market
10. Asia-Pacific ELISpot & FluoroSpot Assay Market
11. Europe, Middle East & Africa ELISpot & FluoroSpot Assay Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- Abcam PLC
- Abnova Corporation
- Agilent Technologies, Inc.
- Anogen-Yes Biotech Laboratories Ltd
- Autoimmun Diagnostika GmbH
- Becton, Dickinson and Company
- Bio-Techne Corporation
- BIOSYS Scientific Devices GmbH
- BOC Sciences
- Broughton Life Sciences Limited
- CellCarta Biosciences Inc.
- Creative Proteomics
- Elabscience
- Full Moon BioSystems, Inc.
- Jackson ImmunoResearch Inc.
- Mabtech AB
- Merck KGaA
- Oxford Immunotec USA, Inc.
- Oy Medix Biochemica Ab
- ProImmune Ltd.
- Quansys Biosciences Inc.
- SBH Sciences
- U-CyTech BV
- ZenBio, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 184 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 313.61 Million |
| Forecasted Market Value ( USD | $ 470.74 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
